AR027558A1 - Proteccion in ovo contra bronquitis infecciosa - Google Patents

Proteccion in ovo contra bronquitis infecciosa

Info

Publication number
AR027558A1
AR027558A1 ARP010100881A AR027558A1 AR 027558 A1 AR027558 A1 AR 027558A1 AR P010100881 A ARP010100881 A AR P010100881A AR 027558 A1 AR027558 A1 AR 027558A1
Authority
AR
Argentina
Prior art keywords
protection against
infectious bronchitis
against infectious
ovo
bronchitis
Prior art date
Application number
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR027558A1 publication Critical patent/AR027558A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invencion está dirigida a procedimientos y composiciones para proteger animales huéspedes (por ejemplo, pollos) contra la exposicion a virusinfecciosos virulentos de bronquitis. La administracion in ovo de cepas vivas, avirulentas de IB a niveles de dosificacion apropiados en una base por huevoprovee una vacunacion eficaz y eficiente que tiene características aceptables y de seguridad y eficacia.
ARP010100881 2000-02-29 2001-02-27 Proteccion in ovo contra bronquitis infecciosa AR027558A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis

Publications (1)

Publication Number Publication Date
AR027558A1 true AR027558A1 (es) 2003-04-02

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100881 AR027558A1 (es) 2000-02-29 2001-02-27 Proteccion in ovo contra bronquitis infecciosa

Country Status (20)

Country Link
EP (2) EP2198883A1 (es)
JP (1) JP2003529565A (es)
CN (1) CN1406135A (es)
AR (1) AR027558A1 (es)
AT (1) ATE463253T1 (es)
AU (1) AU2001237016A1 (es)
BR (1) BR0108735A (es)
CA (1) CA2401145A1 (es)
CY (1) CY1110544T1 (es)
DE (1) DE60141743D1 (es)
DK (1) DK1259257T3 (es)
ES (1) ES2341841T3 (es)
IL (1) IL151039A0 (es)
MX (1) MXPA02008254A (es)
NO (1) NO20024100L (es)
NZ (1) NZ520761A (es)
PL (1) PL365447A1 (es)
PT (1) PT1259257E (es)
WO (1) WO2001064244A2 (es)
YU (1) YU65102A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
DE602004023594D1 (de) 2003-03-03 2009-11-26 Inst Animal Health Newbury Ein virus der infektiösen bronchitis mit veränderten spike-gen
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
KR20190021334A (ko) 2016-06-16 2019-03-05 베링거잉겔하임베트메디카게엠베하 감염성 기관지염 바이러스에 대한 백신
BR112021008390A2 (pt) 2018-10-31 2021-09-28 Boehringer Ingelheim Vetmedica Gmbh Vacina de ibv h52 com proteína da espícula heteróloga
CN120290498A (zh) 2018-10-31 2025-07-11 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
WO2020229257A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Attenuated ibv with extended cell culture and tissue tropism
CN114174321B (zh) 2019-05-10 2025-04-25 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s2亚基
EP3965812A1 (en) 2019-05-10 2022-03-16 Boehringer Ingelheim Vetmedica GmbH Modified s1 subunit of the coronavirus spike protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426051T2 (de) * 1993-07-30 2001-05-10 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff für Geflügel
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
NZ520761A (en) 2004-10-29
DK1259257T3 (da) 2010-06-14
CY1110544T1 (el) 2015-04-29
YU65102A (sh) 2005-09-19
MXPA02008254A (es) 2003-02-06
JP2003529565A (ja) 2003-10-07
CN1406135A (zh) 2003-03-26
DE60141743D1 (de) 2010-05-20
AU2001237016A1 (en) 2001-09-12
NO20024100D0 (no) 2002-08-28
IL151039A0 (en) 2003-04-10
WO2001064244A2 (en) 2001-09-07
ATE463253T1 (de) 2010-04-15
BR0108735A (pt) 2002-12-17
WO2001064244A3 (en) 2002-01-31
EP2198883A1 (en) 2010-06-23
PT1259257E (pt) 2010-06-01
ES2341841T3 (es) 2010-06-29
CA2401145A1 (en) 2001-09-07
EP1259257B1 (en) 2010-04-07
EP1259257A2 (en) 2002-11-27
NO20024100L (no) 2002-10-09
PL365447A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
CY1110544T1 (el) Προστασια εντος ωου εναντι λοιμωδους βρογχιτιδας
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
AR020134A1 (es) Antigenos inmunologicos contra el virus herpes simplex y metodos para el uso de los mismos
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
HRP20040195B1 (hr) Cjepivo protiv bolesti zapadnoga nila
MX9709870A (es) Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis.
ES2155129T3 (es) Vacunacion in ovo contra la coccidiosis.
DE60336927D1 (es)
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
MX2022000948A (es) Vacuna de una sola dosis contra el virus chikunguña.
WO2007135420A3 (en) Defective interfering virus
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
CY1106707T1 (el) Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας
BRPI0508660A (pt) composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa
BR0003164A (pt) Mutante ndv, vacinas viva e inativada contra doença de newcastle em aves, uso de um mutante ndv, e, processo de proteção de aves contra nd
ES2068322T3 (es) Vacuna contra los corona virus caninos.
Berhanu Vaccine containing immunologic adjuvants with a wide range of activity to provide protection against COVID-19
CO4790102A1 (es) Vacuna contra la bursitis infecciosa
BR0100695A (pt) Vìrus de anemia de galinhas (cav), processo a preparação deste, vacina para a proteção de aves domésticas contra estados de doença resultantes de uma infecção por cav, processo para a preparação da mesma, uso de um cav, e, processo para o controle de estados de doença que resultam de uma infecção por cav em aves domésticas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal